WO2023276272A1 - Composition liquide de nettoyant pour la peau - Google Patents
Composition liquide de nettoyant pour la peau Download PDFInfo
- Publication number
- WO2023276272A1 WO2023276272A1 PCT/JP2022/008683 JP2022008683W WO2023276272A1 WO 2023276272 A1 WO2023276272 A1 WO 2023276272A1 JP 2022008683 W JP2022008683 W JP 2022008683W WO 2023276272 A1 WO2023276272 A1 WO 2023276272A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- skin cleanser
- liquid skin
- cleanser composition
- component
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 239000007788 liquid Substances 0.000 title claims abstract description 81
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 claims abstract description 19
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims abstract description 16
- 229920006317 cationic polymer Polymers 0.000 claims abstract description 16
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical compound C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 claims abstract description 16
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims abstract description 15
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 11
- 229920000642 polymer Polymers 0.000 claims abstract description 7
- NPSSWQJHYLDCNV-UHFFFAOYSA-N prop-2-enoic acid;hydrochloride Chemical compound Cl.OC(=O)C=C NPSSWQJHYLDCNV-UHFFFAOYSA-N 0.000 claims description 14
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- 239000011591 potassium Substances 0.000 claims description 12
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 claims description 4
- 235000019828 potassium polyphosphate Nutrition 0.000 claims description 4
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 4
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims description 4
- -1 fatty acid salt Chemical class 0.000 description 55
- 239000006260 foam Substances 0.000 description 39
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 36
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 27
- 238000001035 drying Methods 0.000 description 25
- 238000005187 foaming Methods 0.000 description 24
- 235000014113 dietary fatty acids Nutrition 0.000 description 22
- 239000000194 fatty acid Substances 0.000 description 22
- 229930195729 fatty acid Natural products 0.000 description 22
- 238000011156 evaluation Methods 0.000 description 17
- 229910052708 sodium Inorganic materials 0.000 description 17
- 239000011734 sodium Substances 0.000 description 17
- 238000005406 washing Methods 0.000 description 17
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 15
- 229940024606 amino acid Drugs 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 15
- 235000001014 amino acid Nutrition 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 12
- 235000011118 potassium hydroxide Nutrition 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 239000000344 soap Substances 0.000 description 10
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000004677 Nylon Substances 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 229920001778 nylon Polymers 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229910000160 potassium phosphate Inorganic materials 0.000 description 5
- 235000011009 potassium phosphates Nutrition 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- KTCCLEVCNRHWQL-UHFFFAOYSA-N 3-(2-oxotridecylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)CNCCC(O)=O KTCCLEVCNRHWQL-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 229940073490 sodium glutamate Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Chemical class 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229940105132 myristate Drugs 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 229940114930 potassium stearate Drugs 0.000 description 2
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 2
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229940057950 sodium laureth sulfate Drugs 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 2
- ZNYIJXQYUNSKDX-NTISSMGPSA-M sodium;hydron;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O ZNYIJXQYUNSKDX-NTISSMGPSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229940114926 stearate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- DCVMAYAWOPBYKB-UHFFFAOYSA-N 3-[methyl(tetradecanoyl)amino]propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCC(O)=O DCVMAYAWOPBYKB-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010054404 Adenylyl-sulfate kinase Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MYGVPKMVGSXPCQ-JEDNCBNOSA-N Methylmethionine sulfonium salt Chemical compound [Cl-].C[S+](C)CC[C@H](N)C(O)=O MYGVPKMVGSXPCQ-JEDNCBNOSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102100039024 Sphingosine kinase 1 Human genes 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- JUGFVVYVVZCPIT-UHFFFAOYSA-N [K].CCCCCCCCCCCC(=O)N(C)CCC(O)=O Chemical compound [K].CCCCCCCCCCCC(=O)N(C)CCC(O)=O JUGFVVYVVZCPIT-UHFFFAOYSA-N 0.000 description 1
- SNYHHRATSHXAPP-UHFFFAOYSA-N [Na].CCCCCCCCCCCCCC(=O)N(CC(O)=O)CCC(O)=O Chemical compound [Na].CCCCCCCCCCCCCC(=O)N(CC(O)=O)CCC(O)=O SNYHHRATSHXAPP-UHFFFAOYSA-N 0.000 description 1
- OBHAIFOMZXGPIA-DFWYDOINSA-N [Na].CN[C@@H](C)C(O)=O Chemical compound [Na].CN[C@@H](C)C(O)=O OBHAIFOMZXGPIA-DFWYDOINSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- ZITKDVFRMRXIJQ-UHFFFAOYSA-N dodecane-1,2-diol Chemical compound CCCCCCCCCCC(O)CO ZITKDVFRMRXIJQ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940049256 laureth-4 carboxylic acid Drugs 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229940045790 sodium lauryl glycol carboxylate Drugs 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- UIGBPGNEWMRLGK-UHFFFAOYSA-M sodium;2-(2-hydroxydodecoxy)acetate Chemical compound [Na+].CCCCCCCCCCC(O)COCC([O-])=O UIGBPGNEWMRLGK-UHFFFAOYSA-M 0.000 description 1
- DONVGTHTQJQEDC-UHFFFAOYSA-M sodium;2-(2-oxopentadecylamino)acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)CNCC([O-])=O DONVGTHTQJQEDC-UHFFFAOYSA-M 0.000 description 1
- KHCOJQDJOCNUGV-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CC([O-])=O KHCOJQDJOCNUGV-UHFFFAOYSA-M 0.000 description 1
- LOBXNKKFDKXXQW-UHFFFAOYSA-M sodium;3-[dodecanoyl(methyl)amino]propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CCC([O-])=O LOBXNKKFDKXXQW-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Definitions
- the present invention relates to a liquid skin cleanser composition.
- liquid skin cleansing compositions such as hand soaps and body soaps have been desired to have good foam performance such as foam retention and to impart a moist feeling to the skin after cleansing.
- foamy body soap expelled from foamer containers has become more popular.
- Demands are increasing for uses such as washing the body by including soap in washing tools.
- the foam performance the speed of foaming and the density of the foam
- the moist feeling of the skin after washing are fully satisfactory. It was nothing.
- a liquid skin containing a fatty acid salt and a cationic polymer having a structural unit derived from dimethyldiallylammonium chloride for the purpose of imparting good skin feel (moisturizing, smoothness, etc.) after cleansing and good foam performance.
- a detergent composition has been proposed (see, for example, Patent Document 1).
- the liquid skin cleanser composition in the above proposal has a rapid lathering rate and a dense lather when lathered with a cleansing tool such as a nylon towel or a cotton towel, and the moist feeling of the skin after drying with a towel. Dischargeability from the foamer container was not satisfactory.
- the object of the present invention is to solve the above-mentioned problems in the past and to achieve the following objects. That is, the moist feeling on the skin after towel-drying, the lack of stickiness on the skin after towel-drying, the dischargeability from the foamer container, and the speed and density of foaming when washing with a body washing towel.
- An object of the present invention is to provide a liquid skin cleanser composition which is excellent in
- the liquid skin cleansing composition of the present invention comprises (A) an anionic surfactant, (B) a dimethyldiallylammonium chloride polymer, and containing at least one cationic polymer selected from dimethyldiallylammonium chloride-acrylic acid copolymers and (C) potassium phosphate;
- the molar ratio of structural units derived from diallylammonium is 40% or more, and the mass ratio [(B)/(C)] of the content of component (B) to the content of component (C) is 0.
- the present invention is based on the findings of the present inventors, and means for solving the above problems are as follows.
- A an anionic surfactant
- B at least one cationic polymer selected from dimethyldiallylammonium chloride polymer and dimethyldiallylammonium chloride-acrylic acid copolymer
- C phosphorus and a potassium salt of an acid, wherein the molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer is 40% or more, and the above relative to the content of the component
- C A liquid skin cleanser composition characterized in that the mass ratio [(B)/(C)] of the content of component (B) is 0.2 or more and 8.0 or less, and is filled in a foamer container.
- the content of the component (A) is 10% by mass or more and 25% by mass or less with respect to the total amount of the liquid skin cleanser composition
- the content of the component (B) is the liquid skin cleanser composition. 0.2% by mass or more and 0.8% by mass or less based on the total amount of the liquid skin cleanser composition
- the content of the component (C) is 0.1% by mass or more based on the total amount of the liquid skin cleanser composition.
- the above-mentioned problems in the conventional art can be solved and the above-mentioned objects can be achieved. Also, it is possible to provide a liquid skin cleanser composition which is excellent in foaming speed and foam density when washed with a body washing towel.
- the liquid skin cleanser composition of the present invention comprises (A) an anionic surfactant and (B) at least one cation selected from dimethyldiallylammonium chloride polymers and dimethyldiallylammonium chloride-acrylic acid copolymers. and (C) a potassium phosphate salt, and if necessary, further contain other components.
- the (A) anionic surfactant is at least one selected from "(A) component", (B) dimethyldiallylammonium chloride polymer, and dimethyldiallylammonium chloride-acrylic acid copolymer.
- the cationic polymer of is sometimes referred to as "(B) component” or "(B) cationic polymer”
- (C) potassium phosphate is sometimes referred to as "(C) component".
- the (A) anionic surfactant is contained in order to improve the speed of foaming and the density of foam when washing with a body washing towel.
- speed of foaming when washing with a body washing towel means “speed of foaming”
- disenseness of foam when washing with a body washing towel means “ It is sometimes referred to as "foam density”.
- the anionic surfactant of component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. , amino acid-based surfactants, and the like. Among these, higher fatty acid salts are preferred from the viewpoint of improving foaming speed and foam density. These may be used individually by 1 type, and may use 2 or more types together.
- the higher fatty acid salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include laurate, myristate, palmitate and stearate. Among these, higher fatty acid salts containing all of laurate, myristate, palmitate and stearate are preferred from the viewpoint of improving foaming speed and foam density. These may be used individually by 1 type, and may use 2 or more types together.
- the salt in the higher fatty acid salt is not particularly limited and can be appropriately selected depending on the intended purpose.
- examples thereof include alkali metal salts, amine salts, amino acid salts and the like.
- the alkali metal salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium salt and potassium salt.
- the amine salt is not particularly limited and can be appropriately selected depending on the intended purpose. and alkanolamine salts such as -amino-2-methylpropanediol.
- the amino acid salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include lysine salts and arginine salts. Among these, alkali metal salts are preferred, and potassium salts are more preferred.
- the higher fatty acid salt an appropriately synthesized one may be used, or a commercially available product may be used.
- the method for synthesizing the higher fatty acid salt is not particularly limited and can be appropriately selected according to the intended purpose.
- a higher fatty acid salt may be synthesized by a neutralization reaction between a higher fatty acid and an alkali such as potassium hydroxide in a mixing tank in the course of compounding the products.
- NIKKOL potassium laurate LK-120 potassium laurate
- NIKKOL potassium myristate MK-140 potassium myristate
- Thai Soap MNK-40 coconut oil fatty acid Potassium
- Nonsal PK-1 potassium palmitate
- Nonsal SK-1 potassium stearate
- polyoxyethylene alkyl ether sulfate is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include compounds represented by the following general formula (A1).
- the said polyoxyethylene alkyl ether sulfate may be used individually by 1 type, and may use 2 or more types together.
- R 7 represents an alkyl group, and the number of carbon atoms in the alkyl group portion is preferably 10 to 14.
- n represents the average added mole number of ethylene oxide (E.O.), and the average added mole number of the ethylene oxide is preferably 1-5.
- X represents an alkali metal or ammonium.
- the alkali metal is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium and potassium.
- polyoxyethylene alkyl ether sulfate examples include polyoxyethylene (1) sodium lauryl ether sulfate, polyoxyethylene (2) sodium lauryl ether sulfate (also known as POE (2) sodium laureth sulfate), polyoxyethylene (3) sodium lauryl ether sulfate (also known as POE (3) sodium laureth sulfate), polyoxyethylene (4) sodium lauryl ether sulfate, polyoxyethylene (5) sodium lauryl ether sulfate, polyoxyethylene (3) alkyl (C12 , 13) sodium ether sulfate, polyoxyethylene (2) ammonium lauryl ether sulfate, polyoxyethylene (3) ammonium lauryl ether sulfate, and the like.
- the numerical value in said () represents the average addition mole number (n) of ethylene oxide (E.O.).
- polyoxyethylene alkyl ether sulfate an appropriately synthesized one may be used, or a commercially available product may be used.
- Commercially available products of the polyoxyethylene alkyl ether sulfate include, for example, Texapon (registered trademark) N70 (polyoxyethylene (2) sodium lauryl ether sulfate) (manufactured by BASF), Shinorin SPE- 1250 (polyoxyethylene (2) sodium lauryl ether sulfate) (manufactured by New Japan Chemical Co., Ltd.) and the like.
- the ether carboxylate is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include compounds represented by the following general formula (A2) or (A3).
- the ether carboxylates may be used singly or in combination of two or more.
- R 8 is a linear or branched alkyl group or alkenyl group having 5 to 23 carbon atoms, or a linear or branched alkyl group having 5 to 23 carbon atoms, or It represents a phenyl group substituted with an alkenyl group, and the R 8 portion preferably has 10 to 14 carbon atoms.
- R 9 may be the same or different and represents an alkylene group having 2 to 4 carbon atoms, preferably 2 carbon atoms.
- o represents an average added mole number of 1 to 20 alkylene oxide, and the average added mole number of the alkylene oxide is preferably 1 to 5.
- M1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
- ether carboxylate represented by the general formula (A2) or (A3) include polyoxyethylene (3) sodium lauryl ether acetate, polyoxyethylene (4) potassium lauryl ether acetate, and sodium lauryl glycol acetate. etc.
- the numerical value in said () represents the average added mole number (o) of alkylene oxide.
- the ether carboxylate may be appropriately synthesized or may be a commercially available product.
- Commercially available ether carboxylates include, for example, trade names Enagicol EC-30 (polyoxyethylene (3) sodium lauryl ether acetate) (manufactured by Lion Specialty Chemicals Co., Ltd.), Beaulight LCA-25F ( Polyoxyethylene (3) sodium lauryl ether acetate), Beaulite LCA-30D (polyoxyethylene (3) sodium lauryl ether acetate), Beaulite LCA-H (polyoxyethylene (4) lauryl ether acetic acid), Beaulite LCA -25NH (laureth-4 carboxylic acid), Beaulite SHAA (sodium lauryl glycol carboxylate), Beaulite LCA (polyoxyethylene (3) sodium lauryl ether acetate) (manufactured by Sanyo Chemical Industries, Ltd.), Kao Akipo RLM- 45NV (polyoxyethylene (4.5) sodium lauryl ether acetate), Kaohakipo R
- amino acid-based surfactant is not particularly limited and can be appropriately selected depending on the purpose. Examples thereof include compounds represented by the following general formula (A4).
- the amino acid-based surfactants may be used singly or in combination of two or more.
- R 10 is a straight or branched chain alkyl group or alkenyl group having 5 to 23 carbon atoms, or a straight or branched chain alkyl group or alkenyl group having 5 to 23 carbon atoms. It represents a substituted phenyl group, and the R 10 portion preferably has 8 to 18 carbon atoms.
- R 11 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
- R 12 and R 13 may be the same or different and represent a hydrogen atom or —(CH 2 ) m —COOM 2 .
- m and n may be the same or different and each represents a number of 0-20.
- M 1 and M 2 may be the same or different and represent a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
- the amino acid structure of the hydrophilic portion of the amino acid-based surfactant is not particularly limited and can be appropriately selected depending on the purpose, but glycine, glutamic acid, and methylalanine are preferred.
- amino acid-based surfactant represented by the general formula (A4) include N-acyl-glycine such as N-cocoyl-glycine potassium (N-coconut fatty acid acylglycine potassium) and salts thereof; N-acyl-N-carboxyethyl-glycine such as sodium myristoyl-N-carboxyethyl-glycine and salts thereof; sodium N-myristoyl-L-glutamate, potassium N-myristoyl-L-glutamate, N-coconut fatty acid acyl- Potassium L-glutamate, sodium N-palm fatty acid acyl-L-glutamate, N-acylglutamic acid and its salts such as sodium N-stearoyl-L-glutamate; N-lauroyl-N-methyl- ⁇ -alanine potassium, etc. .
- N-acyl-glycine such as N-cocoyl-glycine potassium (N-coconut fatty acid acy
- amino acid-based surfactant an appropriately synthesized one may be used, or a commercially available product may be used.
- Commercially available amino acid-based surfactants include, for example, trade names of Amylite (registered trademark) GCK-11 (potassium N-coconut oil fatty acid acylglycine) and Amylite (registered trademark) GCK-12K (N-coconut oil Potassium fatty acid acylglycinate), Amylite (registered trademark) GCS-12K (sodium N-coconut acylglycinate), Amylite (registered trademark) GCS-11 (sodium N-coconut acylglycinate), Amisoft (registered trademark) CS -11 (N-myristoyl-L-sodium glutamate), Amisoft (registered trademark) CS-22 (N-coconut fatty acid acyl-L-glutamate sodium), Amisoft (registered trademark) LS-11 (N-lauroyl-L-
- the total content of the component (A) contained in the liquid skin cleanser composition of the present invention is not particularly limited and can be appropriately selected depending on the intended purpose. and from the point of improving the dischargeability from the foamer container, the total amount of the liquid skin cleanser composition is preferably 8% by mass or more and 30% by mass or less, and more preferably 10% by mass or more and 25% by mass or less. preferable.
- the total content of component (A) is 8% by mass or more relative to the total amount of the liquid skin cleanser composition, a liquid skin cleanser composition with excellent foaming speed and foam density can be obtained. can be done.
- the total content of the anionic surfactants as component (A) is 30% by mass or less relative to the total amount of the liquid skin cleanser composition, the liquid skin cleanser composition can be excellently ejected from a foamer container. Obtainable.
- the (B) cationic polymer is at least one selected from a dimethyldiallylammonium chloride polymer and a dimethyldiallylammonium chloride-acrylic acid copolymer, and can improve the moist feeling of the skin after drying with a towel. can.
- the component (B) may be used alone or in combination of two or more.
- the dimethyldiallylammonium chloride-acrylic acid copolymer in component (B) is represented by the following general formula (B1).
- n and m represent the molar ratio (mol%) of each structural unit.
- the molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer is 40 mol % or more.
- a composition can be obtained.
- the molar ratio of structural units derived from dimethyldiallylammonium chloride in the dimethyldiallylammonium chloride-acrylic acid copolymer is preferably 65 mol% or more from the viewpoint of improving the moist feeling of the skin after drying with a towel. 95 mol % or more is more preferable.
- the dimethyldiallylammonium chloride-acrylic acid copolymer may be used alone or in combination of two or more.
- the content of the cationic polymer (B) is not particularly limited and can be appropriately selected according to the intended purpose. 0.1% by mass or more and 1% by mass or less is preferable, and 0.2% by mass or more and 0.8% by mass or less is more preferable with respect to the total amount.
- the content of the component (B) is 0.1% by mass or more relative to the total amount of the liquid skin cleanser composition, it is possible to obtain a liquid skin cleanser composition that provides excellent moist feeling on the skin after drying with a towel. can be done.
- the content of the component (B) is 1% by mass or less relative to the total amount of the liquid skin cleanser composition, it is possible to obtain a liquid skin cleanser composition that provides excellent moist feeling on the skin after drying with a towel. .
- the molar ratio of each structural unit in the dimethyldiallylammonium chloride-acrylic acid copolymer in the component (B) can be determined by nuclear magnetic resonance (NMR) measurement under the following measurement conditions.
- NMR nuclear magnetic resonance
- the weight-average molecular weight of the cationic polymer (B) is not particularly limited and can be appropriately selected depending on the intended purpose. ,000, more preferably 15,000 to 450,000.
- the weight average molecular weight of the cationic polymer (B) is measured by, for example, the SEC-MALLS-RI system (measurement conditions: column: TSKgel ⁇ series ⁇ -M column 30 cm manufactured by Tosoh Corporation, solvent: sodium nitrate 0.3M aqueous solution). can do.
- the viscosity of the (B) cationic polymer solution with a solid content of 30% by mass to 44% by mass at 25° C. is preferably 10 mPa ⁇ s to 15,000 mPa ⁇ s, more preferably 20 mPa ⁇ s to 12,000 mPa ⁇ s. .
- the viscosity can be measured, for example, using a Brookfield viscometer LVF (manufactured by Brookfield).
- the (B) cationic polymer may be appropriately synthesized or may be a commercially available product.
- Commercially available cationic polymers (B) include, for example, MERQUAT 100, MERQUAT 106, MERQUAT 280, and MERQUAT 295 (all manufactured by Lubrizol). The composition, physical properties, etc. of each commercial product are shown below.
- the potassium phosphate of component (C) is contained to improve the speed of foaming.
- the component (C) is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include potassium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium tripolyphosphate, and potassium polyphosphate. Among these, potassium dihydrogen phosphate is preferable from the viewpoint of improving the speed of foaming.
- the component (C) may be used alone or in combination of two or more.
- the content of the component (C) is 0.05 mass based on the total amount of the liquid skin cleanser composition, from the viewpoint of improving the speed of foaming and the moist feeling of the skin after drying with a towel. % or more and 2.0 mass % or less is preferable, and 0.1 mass % or more and 1.0 mass % or less is more preferable.
- the content of component (C) is 0.05% by mass or more relative to the total amount of the liquid skin cleanser composition, it is possible to obtain a liquid skin cleanser composition that foams quickly.
- the content of component (C) is 2.0% by mass or less relative to the total amount of the liquid skin cleanser composition, it is possible to obtain a liquid skin cleanser composition that provides good moist feeling on the skin after drying with a towel. can be done.
- component (C)component what was synthesize
- the method for synthesizing the component (C) is not particularly limited and can be appropriately selected according to the intended purpose.
- Commercially available products of component (C) include, for example, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium tripolyphosphate, and potassium polyphosphate (manufactured by Taiheiyo Kagaku Sangyo Co., Ltd.). These may be used individually by 1 type, and may use 2 or more types together.
- the mass ratio [(B)/(C)] of the content of the component (B) to the content of the component (C) is 0.2 or more and 8.0 or less.
- the mass ratio [(B)/(C)] is 0.2 or more, it is possible to obtain a liquid skin cleanser composition that provides excellent moist feeling on towel-dried skin.
- the mass ratio [(B)/(C)] is 8.0 or less, it is possible to obtain a liquid skin cleanser composition which is excellent in non-stickiness on towel-dried skin and in rapid foaming. can.
- the mass ratio [(B)/(C)] of the content of component (B) to the content of component (C) is the moist feeling on the skin after towel-drying and the stickiness on the skin after towel-drying. It is preferably 0.4 or more and 4.0 or less, more preferably 0.4 or more and 1.4 or less, from the viewpoint of improving the smoothness and speed of foaming.
- the liquid skin cleanser composition of the present invention may optionally contain other ingredients as long as the effects of the present invention are not impaired. can be blended.
- the other components include surfactants other than component (A), water-soluble polymers other than component (B), oils, silicones, alcohols such as lower or higher alcohols, lanolin derivatives, protein derivatives, Medicines such as amino acids and vitamins, disinfectants, moisturizers, preservatives, pH adjusters such as potassium hydroxide, citric acid and hydrochloric acid, antioxidants, sequestering agents, ultraviolet absorbers, ultraviolet scattering agents, animal and plant extracts substances or derivatives thereof, chelating agents such as edetic acid, dyes, perfumes, pigments, inorganic powders, clay minerals, nylon, water-insoluble polymer compound powders such as polyethylene, and the like.
- liquid skin cleanser composition is not particularly limited and can be appropriately selected according to the purpose.
- the oil is not particularly limited and can be appropriately selected depending on the intended purpose.
- vegetable oils and fats and their ester compounds mink oil, egg yolk oil and other animal oils and fats, beeswax, whale wax, lanolin, hydrogenated lanolin, carnauba wax, candelilla wax and other waxes, liquid paraffin, squalane, microcrystalline wax , ceresin wax, paraffin wax, petrolatum and other hydrocarbons, oleic acid, isostearic acid, behenic acid and other natural and synthetic fatty acids, glycerol tri-2-ethylhexanoate, 2-ethylhexyl stearate, butyl stearate, Isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, octyldodecyl oleate, esters such as cholesterol oleate, and the like.
- the content of the oil is
- the alcohols are not particularly limited and can be appropriately selected depending on the purpose. Examples include natural and synthetic higher alcohols such as cetyl alcohol, oleyl alcohol, stearyl alcohol, hexyldecanol, octyldodecanol, and lauryl alcohol. .
- the content of the alcohol is not particularly limited and can be appropriately selected depending on the purpose, but is preferably 0.1% by mass or more and 10% by mass or less.
- the moisturizing agent is not particularly limited and can be appropriately selected depending on the intended purpose. , diglycerin, triglycerin, and polyglycerin.
- the preservative is not particularly limited and can be appropriately selected depending on the intended purpose. Hydroxydiphenyl ether, 3,4,4'-trichlorocarbanilide, benzalkonium chloride, hinokitiol, resorcinol, methylchloroisothiazolinone/methylisothiazolinone liquid (trade name: Kason CG, Rohm and Haas Japan Co., Ltd.) ), salicylic acid, pentanediol, phenoxyethanol, ethanol, and the like.
- the content of the preservative is not particularly limited and can be appropriately selected depending on the purpose, but is preferably 0.1% by mass or more and 1% by mass or less.
- the antioxidant is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include dibutylhydroxytoluene, butylhydroxyanisole, and ascorbic acid.
- the content of the antioxidant is not particularly limited and can be appropriately selected depending on the purpose, but is preferably 0.1% by mass or more and 1% by mass or less.
- the chelating agent is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include disodium edetate, ethylenediaminetetraacetate, hexametaphosphate and gluconic acid.
- the content of the chelating agent is not particularly limited and can be appropriately selected according to the purpose, but is preferably 0.1% by mass or more and 1% by mass or less.
- the pH adjuster is not particularly limited and can be appropriately selected depending on the purpose. Examples include sodium hydroxide, potassium hydroxide, citric acid, succinic acid, triethanolamine, aqueous ammonia, triisopropanolamine, phosphoric acid, Glycolic acid and the like can be mentioned.
- the ultraviolet absorber and the ultraviolet scattering agent are not particularly limited and can be appropriately selected depending on the intended purpose. kaolin, talc and the like.
- the vitamins are not particularly limited and can be appropriately selected depending on the purpose. Examples include vitamin A, vitamin B group, vitamin C, vitamin D, vitamin E, vitamin F, vitamin K, vitamin P, vitamin U, carnitine , ferulic acid, ⁇ -oryzanol, ⁇ -lipoic acid, orotic acid and derivatives thereof.
- the content of the vitamins is not particularly limited and can be appropriately selected depending on the purpose, but is preferably 0.001% by mass or more and 0.5% by mass or less.
- the amino acids are not particularly limited and can be appropriately selected depending on the intended purpose. , arginine, histidine, lysine and derivatives thereof.
- the content of the amino acids is not particularly limited and can be appropriately selected depending on the purpose, but is preferably 0.001% by mass or more and 0.5% by mass or less.
- the pH of the liquid skin cleanser composition at 25° C. is preferably from 9.5 to 11.0, more preferably from 9.8 to 10.6.
- the method for measuring the pH is not particularly limited, but examples thereof include a method of measuring using a glass electrode color hydrogen ion concentration indicator HM-30R (electrode type GST-5721 manufactured by Toa DKK Co., Ltd.). .
- the viscosity of the liquid skin cleanser composition at 25°C is not particularly limited and may be appropriately selected according to the intended purpose. ⁇ s or more and 30 mPa ⁇ s or less is preferable, and 15 mPa ⁇ s or more and 25 mPa ⁇ s or less is more preferable.
- the method for measuring the viscosity is not particularly limited. and a method of measuring the viscosity after 1 minute with one rotor.
- the liquid skin cleanser composition of the present invention is of a type that is filled in a foamer container and discharged from the foamer container in the form of foam.
- the foamer container is not particularly limited as long as it can discharge the liquid skin cleanser composition in the form of foam, and can be appropriately selected according to the purpose. and a pressure-resistant container. Among these, a non-gas type bubble dispenser is preferable.
- the non-gas type foam dispenser is not particularly limited as long as it can mix the liquid skin cleanser composition with air and discharge it in a foamed state.
- Examples include a squeeze foamer container in which foam can be discharged by squeezing the portion by hand, and a pump foamer container in which foam can be discharged by pushing down the nozzle portion.
- a squeeze foamer container and the pump foamer container for example, a foamer container manufactured by Yamato Seikan Co., Ltd., a foamer container manufactured by Yoshino Kogyosho Co., Ltd., and the like can be used. More specifically, the former containers and the like described in JP-A-7-315463, JP-A-8-230961, and JP-A-2005-193972 can be used.
- the non-gas type foam dispenser usually has a porous membrane for forming foam, and foam is formed by passing the liquid skin cleanser composition through the porous membrane.
- the material of the porous membrane is not particularly limited and can be appropriately selected according to the purpose, but plastic materials such as nylon, polyester, polyolefin, etc. are preferable.
- the mesh of the porous membrane is not particularly limited and can be appropriately selected according to the purpose. More preferred are:
- the number of the porous membranes is not particularly limited and can be appropriately selected depending on the intended purpose. More specifically, the former containers described in JP-A-7-315463, JP-A-8-230961, and JP-A-2005-193972 can be preferably used.
- the room temperature condition is 25°C.
- the viscosity of the liquid skin cleansing composition below is preferably 30 mPa ⁇ s or less, more preferably 25 mPa ⁇ s or less.
- the method for producing the liquid skin cleanser composition of the present invention is not particularly limited and can be appropriately selected according to the purpose.
- the other components and purified water (blended as the remaining amount so that the entire liquid skin cleansing composition is 100% by mass) can be mixed.
- it can be manufactured as follows. After dissolving the (A) component and the (C) component in purified water heated to 70° C. to 80° C., cooling to 40° C. or less, adding the (B) component and other components. It can be manufactured by
- the liquid skin cleanser composition may be prepared using an apparatus.
- the device is not particularly limited and can be appropriately selected depending on the intended purpose.
- the stirring blade is not particularly limited and can be appropriately selected depending on the purpose. Examples thereof include propellers, turbines, and dispersers.
- the application site and application method of the liquid skin cleanser composition are not particularly limited and can be appropriately selected according to the intended purpose. can.
- the use of the liquid skin cleanser composition is not particularly limited and can be appropriately selected according to the intended purpose. etc.
- Liquid skin cleansing compositions having compositions and contents shown in Tables 1 to 6 below were prepared by the following method. Purified water in an amount of 95% by mass of the total amount of the liquid skin cleanser composition finally obtained is heated to 70° C. to 80° C., and the anionic surfactant of component (A) and component (C) are A potassium phosphate salt or a comparative component of component (C) was dissolved. Then, after cooling to 40° C. or less, the cationic polymer of component (B) or the comparative component of component (B) and other components were added to prepare a liquid skin cleanser composition.
- Liquid skin cleanser compositions of Examples 1 to 25 and Comparative Examples 1 to 7 were obtained.
- the mixture was stirred using a three-one motor (HEIDON BL1200, manufactured by Shinto Kagaku Co., Ltd.), and a propeller was used as the stirring blade.
- the pH of the obtained liquid skin cleanser compositions of Examples 1 to 25 and Comparative Examples 1 to 7 was measured at 25° C. using a pH meter (HM-30R; manufactured by TOA DKK).
- the resulting liquid skin cleanser compositions of Examples 1 to 25 and Comparative Examples 1 to 7 were filled into a container with a foamer pump dispenser (discharge volume 3 mL, manufactured by Yoshino Kogyosho Co., Ltd.).
- 3 points The foam is slightly hard and does not drip even when the hand is turned upside down. The foam is soft and drips when you turn your hand upside down.[Criteria for foam density] ⁇ : 3.5 points or more and 4.0 points or less ⁇ : 3.0 points or more and less than 3.5 points ⁇ : 2.0 points or more and less than 3.0 points ⁇ : Less than 2.0 points
- Potassium laurate was prepared by neutralizing lauric acid (NAA-122, manufactured by NOF Corporation) with potassium hydroxide (manufactured by Asahi Glass Co., Ltd., liquid caustic potash).
- Potassium myristate was prepared by neutralizing myristic acid (NAA-142, manufactured by NOF Corporation) with potassium hydroxide (manufactured by Asahi Glass Co., Ltd., liquid caustic potash).
- Potassium palmitate was prepared by neutralizing palmitic acid (NAA-160, manufactured by NOF Corporation) with potassium hydroxide (liquid caustic potash, manufactured by Asahi Glass Co., Ltd.).
- Potassium stearate was prepared by neutralizing stearic acid (NAA-180, manufactured by NOF Corporation) with potassium hydroxide (liquid caustic potash, manufactured by Asahi Glass Co., Ltd.).
- Perfume is the perfume A to D described in paragraphs [0065] to [0071] of JP-A-2002-128658, and paragraphs [0076] to [0088] of JP-A-2003-73249.
- the liquid skin cleanser composition of the present invention provides a moist feeling on the skin after towel-drying, no stickiness on the skin after towel-drying, dischargeability from the foamer container, and cleansing with a body-cleansing towel. Due to its excellent foaming speed and foam density, it can be suitably used for, for example, body shampoo, body soap, facial cleansing foam, hand soap, foaming hand soap cleansing foam, makeup remover, and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
L'invention concerne une composition liquide de nettoyant pour la peau caractérisée en ce qu'elle comprend : (A) un tensioactif anionique ; (B) au moins un type de polymère cationique choisi parmi un polymère de chlorure de diméthyldiallyl ammonium et un copolymère de chlorure de diméthyldiallyl ammonium-acide acrylique ; et (C) un sel de phosphate de potassium, la fraction molaire d'un motif structural dérivé du chlorure de diméthyldiallyl ammonium dans le copolymère de chlorure de diméthyldiallyl ammonium-acide acrylique n'étant pas inférieure à 40 %, le rapport en masse [(B)/(C)] de la teneur en composant (B) à la teneur en composant (C) est de 0,2 à 8,0, et la composition liquide de nettoyant pour la peau est remplie dans un récipient de moussage.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202280034203.5A CN117295487A (zh) | 2021-06-30 | 2022-03-01 | 液体皮肤清洁剂组合物 |
KR1020237024677A KR20240026877A (ko) | 2021-06-30 | 2022-03-01 | 액체 피부 세정제 조성물 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-108914 | 2021-06-30 | ||
JP2021108914A JP2023006355A (ja) | 2021-06-30 | 2021-06-30 | 液体皮膚洗浄剤組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023276272A1 true WO2023276272A1 (fr) | 2023-01-05 |
Family
ID=84692284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/008683 WO2023276272A1 (fr) | 2021-06-30 | 2022-03-01 | Composition liquide de nettoyant pour la peau |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2023006355A (fr) |
KR (1) | KR20240026877A (fr) |
CN (1) | CN117295487A (fr) |
WO (1) | WO2023276272A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024142440A1 (fr) * | 2022-12-26 | 2024-07-04 | ライオン株式会社 | Composition d'agent nettoyant liquide pour la peau |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5022813A (fr) * | 1973-06-04 | 1975-03-11 | ||
JP2001335442A (ja) * | 2000-05-30 | 2001-12-04 | Shiseido Co Ltd | 洗浄剤組成物 |
JP2020203840A (ja) * | 2019-06-14 | 2020-12-24 | ライオン株式会社 | 液体皮膚洗浄剤組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111295179B (zh) | 2017-11-16 | 2023-09-26 | 狮王株式会社 | 液体皮肤清洁剂组合物 |
-
2021
- 2021-06-30 JP JP2021108914A patent/JP2023006355A/ja active Pending
-
2022
- 2022-03-01 CN CN202280034203.5A patent/CN117295487A/zh active Pending
- 2022-03-01 KR KR1020237024677A patent/KR20240026877A/ko unknown
- 2022-03-01 WO PCT/JP2022/008683 patent/WO2023276272A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5022813A (fr) * | 1973-06-04 | 1975-03-11 | ||
JP2001335442A (ja) * | 2000-05-30 | 2001-12-04 | Shiseido Co Ltd | 洗浄剤組成物 |
JP2020203840A (ja) * | 2019-06-14 | 2020-12-24 | ライオン株式会社 | 液体皮膚洗浄剤組成物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024142440A1 (fr) * | 2022-12-26 | 2024-07-04 | ライオン株式会社 | Composition d'agent nettoyant liquide pour la peau |
Also Published As
Publication number | Publication date |
---|---|
CN117295487A (zh) | 2023-12-26 |
KR20240026877A (ko) | 2024-02-29 |
JP2023006355A (ja) | 2023-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014003114A1 (fr) | Produit liquide nettoyant pour la peau | |
JP6764413B2 (ja) | 皮膚洗浄剤組成物 | |
JP2012153627A (ja) | 皮膚洗浄剤組成物 | |
KR101444502B1 (ko) | 피부 세정료 및 그것을 이용한 피부 세정 방법 | |
WO2023276272A1 (fr) | Composition liquide de nettoyant pour la peau | |
JP7291009B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP7236314B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP7250042B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP2019094287A (ja) | 液体皮膚洗浄剤組成物 | |
JP7204664B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP6654990B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP7286526B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP6726030B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP6745144B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP7349473B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP6831747B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP2023062607A (ja) | 皮膚洗浄剤組成物 | |
JP2022178940A (ja) | 皮膚洗浄剤組成物 | |
WO2024142440A1 (fr) | Composition d'agent nettoyant liquide pour la peau | |
WO2023167114A1 (fr) | Composition nettoyante pour la peau | |
JP6951916B2 (ja) | 液体皮膚洗浄剤組成物 | |
JP2023177999A (ja) | 液体皮膚洗浄剤組成物 | |
JP2023152321A (ja) | 皮膚洗浄剤組成物 | |
JP2023088105A (ja) | 液体皮膚洗浄剤組成物 | |
JP2022147996A (ja) | さらさら感増強剤及び洗浄剤組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22832438 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280034203.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22832438 Country of ref document: EP Kind code of ref document: A1 |